Denali Therapeutics Stock Technical Analysis
| DNLI Stock | USD 16.60 0.22 1.31% |
As of the 19th of April, Denali Therapeutics shows the Coefficient Of Variation of 196441.22, downside deviation of 4.42, and Mean Deviation of 3.29. Denali Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Denali Therapeutics, which can be compared to its peers. Please confirm Denali Therapeutics jensen alpha, as well as the relationship between the potential upside and skewness to decide if Denali Therapeutics is priced favorably, providing market reflects its regular price of 16.6 per share. Given that Denali Therapeutics has jensen alpha of (0.23), we urge you to verify Denali Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.
Denali Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Denali, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DenaliDenali |
Denali Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 55.6 | Strong Buy | 17 | Odds |
Most Denali analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Denali stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Denali Therapeutics, talking to its executives and customers, or listening to Denali conference calls.
Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Denali Therapeutics Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Denali Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Denali Therapeutics Trend Analysis
Use this graph to draw trend lines for Denali Therapeutics. You can use it to identify possible trend reversals for Denali Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Denali Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Denali Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Denali Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Denali Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 59.33, which is the sum of squared deviations for the predicted Denali Therapeutics price change compared to its average price change.About Denali Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Denali Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Denali Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Denali Therapeutics price pattern first instead of the macroeconomic environment surrounding Denali Therapeutics. By analyzing Denali Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Denali Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Denali Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 20.64 | 22.03 | 13.36 | 12.69 | Receivables Turnover | 39.69 | 21.69 | 122.42 | 128.54 |
Denali Therapeutics April 19, 2024 Technical Indicators
Most technical analysis of Denali help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Denali from various momentum indicators to cycle indicators. When you analyze Denali charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0093 | |||
| Market Risk Adjusted Performance | 0.0081 | |||
| Mean Deviation | 3.29 | |||
| Semi Deviation | 4.35 | |||
| Downside Deviation | 4.42 | |||
| Coefficient Of Variation | 196441.22 | |||
| Standard Deviation | 5.98 | |||
| Variance | 35.82 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0) | |||
| Maximum Drawdown | 51.7 | |||
| Value At Risk | (6.80) | |||
| Potential Upside | 4.94 | |||
| Downside Variance | 19.49 | |||
| Semi Variance | 18.9 | |||
| Expected Short fall | (3.40) | |||
| Skewness | 3.85 | |||
| Kurtosis | 25.69 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.06) | Revenue Per Share 2.406 | Quarterly Revenue Growth (1.00) | Return On Assets (0.09) | Return On Equity (0.14) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.